Advances and disparities in survival of childhood and adolescent cancers

Abstract Background We analyzed trends in survival of children and adolescents diagnosed with cancer in the United States from 1975 to 2022 using the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) 8 and 17 databases. Our goal was to provide an updated overview of outcomes and highlight disparities to guide future research. Methods Data were obtained from the SEER 8 and 17 registries for patients diagnosed at ages 0-19 years. Overall survival was stratified by race and ethnicity, diagnosis, and population density. Temporal trends in 5-year overall survival were evaluated using the National Cancer Institute Joinpoint Regression Program. Kaplan–Meier survival curves with log-rank tests assessed survival differences across subgroups. Multivariable Cox proportional hazards models evaluated overall survival, adjusted for age, decade of diagnosis, and race and ethnicity. Results A total of 52 165 patients were diagnosed with cancer in SEER 8 and 100 110 in SEER 17. Five-year overall survival for all cancers improved from 60% (95% CI = 56% to 64%) in 1975 to 90% (95% CI = 88% to 91%) in 2017. Survival gains were greatest in acute lymphoblastic leukemia, with more modest improvements in solid tumors. Mortality beyond 20 years persisted for some cancers, including Hodgkin lymphoma. Survival differed statistically by race and ethnicity (P  Conclusions Survival for childhood and adolescent cancers has markedly improved over the past 5 decades, yet progress remains uneven across cancer types and race and ethnicity. Understanding drivers of disparities is essential to achieve equitable outcomes for all young cancer patients.